Literature DB >> 3090735

An ELISA test for the binding of von Willebrand antigen to collagen.

J E Brown, J O Bosak.   

Abstract

Collagen (soluble bovine tendon type I) coated onto microtiter plates binds von Willebrand antigen (vW:Ag) in a dose-dependent manner. An ELISA test was set up with both antibody and collagen coated microtiter plates. Test specimens assayed were: 1) normal plasmas, 2) type I vW plasmas, 3) type IIa vW plasmas, and 4) factor VIII concentrates (KoateR, Cutter; Conco-VIII, Green Cross). Normal and type I vW plasmas exhibited comparable values for vW:Ag in binding studies to both collagen and antibody-coated plates. Type IIa vW plasmas demonstrated decreased (less than 1/2) collagen to antibody-binding ratios. Ristocetin cofactor (VIII:RCO) levels in type IIa vW plasmas correlated with quantified collagen-binding levels. Factor VIII concentrates show variable results when comparing collagen and antibody-binding levels. A comparison of vW:Ag ELISA (antibody) with VIII:RCO shows ratios of 2:1 (KoatR) or 20:1 (Conco-VIII). Collagen-binding ELISA levels in concentrates show parallel decreases, reflecting presumed binding to collagen of only the high M.W. multimers. The vW:Ag collagen binding ELISA represents a possible replacement assay for the laborious and imprecise VIII:RCO method of measurement of in vitro vWf functional activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090735     DOI: 10.1016/0049-3848(86)90150-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  17 in total

1.  Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.

Authors:  V H Flood; J C Gill; P A Christopherson; J S Wren; K D Friedman; S L Haberichter; R G Hoffmann; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

2.  Crucial role for the VWF A1 domain in binding to type IV collagen.

Authors:  Veronica H Flood; Abraham C Schlauderaff; Sandra L Haberichter; Tricia L Slobodianuk; Paula M Jacobi; Daniel B Bellissimo; Pamela A Christopherson; Kenneth D Friedman; Joan Cox Gill; Raymond G Hoffmann; Robert R Montgomery
Journal:  Blood       Date:  2015-02-06       Impact factor: 22.113

3.  Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD.

Authors:  V H Flood; C A Lederman; J S Wren; P A Christopherson; K D Friedman; R G Hoffmann; R R Montgomery
Journal:  J Thromb Haemost       Date:  2010-03-23       Impact factor: 5.824

4.  Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.

Authors:  Ian Mackie; C E Eapen; Desley Neil; Andrew S Lawrie; Andrew Chitolie; Jean C Shaw; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2011-05-15       Impact factor: 3.199

5.  Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.

Authors:  K S Prasanna; Ashish Goel; G Jayakumar Amirtharaj; Anup Ramachandran; K A Balasubramanian; Ian Mackie; Uday Zachariah; K G Sajith; Elwyn Elias; C E Eapen
Journal:  Indian J Gastroenterol       Date:  2016-11-08

Review 6.  Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.

Authors:  Veronica H Flood
Journal:  Semin Thromb Hemost       Date:  2013-12-12       Impact factor: 4.180

7.  Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.

Authors:  T Obser; M Ledford-Kraemer; F Oyen; M A Brehm; C V Denis; R Marschalek; R R Montgomery; J E Sadler; S Schneppenheim; U Budde; R Schneppenheim
Journal:  J Thromb Haemost       Date:  2016-08-20       Impact factor: 5.824

8.  Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.

Authors:  V H Flood; K D Friedman; J C Gill; P A Morateck; J S Wren; J P Scott; R R Montgomery
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

9.  Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.

Authors:  P J van Genderen; J J Michiels; S C van der Poel-van de Luytgaarde; H H van Vliet
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

10.  ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?

Authors:  M C Kappers-Klunne; J G van Asten; H H van Vliet
Journal:  Ann Hematol       Date:  2009-02-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.